Healome Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2.66M
- Investors
-
11
Healome Therapeutics General Information
Description
Developer of treatments for eye conditions of ocular diseases designed for eye trauma therapeutics. The company offers novel fluid-gel material that flows like a liquid and self-structures into a thin, clear, protective layer over the surface of the eye, which is gradually dispersed, enabling patients to get effective and longer lasting relief.
Contact Information
Website
www.healometx.comCorporate Office
- Birmingham Research Park
- 97 Vincent Drive
- Birmingham B15 2SQ
- England, United Kingdom
Corporate Office
- Birmingham Research Park
- 97 Vincent Drive
- Birmingham B15 2SQ
- England, United Kingdom
Healome Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | 07-Jul-2026 | $2.66M | Completed | Clinical Trials - Phase 1 | ||
| 4. Seed Round | 21-Oct-2021 | Completed | Clinical Trials - Phase 1 | |||
| 3. Grant | Completed | Clinical Trials - Phase 1 | ||||
| 2. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 1. University Spin-Out | 11-Jan-2021 | Completed | Clinical Trials - Phase 1 |
Healome Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary A | ||||||||
| Ordinary | ||||||||
| Ordinary A | 1,263,158 | $0.000133 | $0.16 | $0.16 | 1x | $0.16 | 8.24% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Healome Therapeutics Signals
Healome Therapeutics Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cure EB | Other | Minority | ||
| DEBRA Research | Corporation | Minority | ||
| Empirical Ventures | Venture Capital | Minority | ||
| Midlands Mindforge | Impact Investing | |||
| Oshen Holdings | Family Office | Minority |
Healome Therapeutics FAQs
-
When was Healome Therapeutics founded?
Healome Therapeutics was founded in 2021.
-
Where is Healome Therapeutics headquartered?
Healome Therapeutics is headquartered in Birmingham, United Kingdom.
-
What is the size of Healome Therapeutics?
Healome Therapeutics has 5 total employees.
-
What industry is Healome Therapeutics in?
Healome Therapeutics’s primary industry is Drug Discovery.
-
Is Healome Therapeutics a private or public company?
Healome Therapeutics is a Private company.
-
What is the current valuation of Healome Therapeutics?
The current valuation of Healome Therapeutics is .
-
What is Healome Therapeutics’s current revenue?
The current revenue for Healome Therapeutics is .
-
How much funding has Healome Therapeutics raised over time?
Healome Therapeutics has raised $3.21M.
-
Who are Healome Therapeutics’s investors?
Cure EB, DEBRA Research, Empirical Ventures, Midlands Mindforge, and Oshen Holdings are 5 of 11 investors who have invested in Healome Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process